LX Medical Corporation Profile last edited on: 1/7/2024
CAGE: 6FUS6
UEI: C155C9LUAK65
Business Identifier: Image guided lung intervention 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 08
County: Norfolk
Congr. District: 08
County: Norfolk
Public Profile
LX Medical Corporation is an early stage firm organized around addressing unmet needs in lung cancer diagnosis and treatment. Principals of the firm have been working on bringing to use condition a suite of endobronchial imaging probes and image-guided bronchoscopic tools. The effort has been that these be used by interventional pulmonologists and thoracic surgeons to improve outcomes in diagnostic and therapeutic medical procedures for several lung diseases.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2017 | 1 | NIH | $223,403 | |
| Project Title: High-Resolution Multi-Modality Endoscopic Imaging Probes for Diagnosing Rejection in Lung Transplant Recipients | ||||
| 2017 | 1 | NIH | $274,283 | |
| Project Title: Biopsy Probes with Real-time Multi-modality Image Guidance for Peripheral Lung Nodules | ||||
Key People / Management
Andrei Vertikov -- CTO
Company News
There are no news available.
